Multifactorial QT interval prolongation

Cardiology Journal

Volumn 17, Issue 2, 2010, Pages 184-188

  Digby, Geneviève ^a   MacHaalany, Jimmy ^a   Malik, Paul ^a   Methot, Michelle ^a   Simpson, Christopher S ^a   Redfearn, Damian ^a   Baranchuk, Adrian ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Acquired long QT interval

Indexed keywords

ACAMPROSATE; AMIODARONE; ATENOLOL; ATORVASTATIN; CITALOPRAM; CLONAZEPAM; DIGOXIN; DOMPERIDONE; FUROSEMIDE; GLIBENCLAMIDE; HYDROCHLOROTHIAZIDE; IRBESARTAN; LEVOTHYROXINE; MAGNESIUM; MAGNESIUM SULFATE; METFORMIN; METOLAZONE; METOPROLOL; MIRTAZAPINE; OMEPRAZOLE; POTASSIUM; QUETIAPINE; RANITIDINE; ROSUVASTATIN; VENLAFAXINE; BIOLOGICAL MARKER; CYCLOHEXANOL DERIVATIVE; DIBENZOTHIAZEPINE DERIVATIVE; DIURETIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; ALCOHOL ABUSE; ALCOHOLISM; ARTICLE; ARTIFICIAL HEART PACEMAKER; BEDTIME DOSAGE; BLOOD ANALYSIS; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; DIAPHORESIS; DISEASE ASSOCIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; ELECTROLYTE DISTURBANCE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOTHYROIDISM; MALAISE; MITRAL VALVE PROSTHESIS; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYPHARMACY; QT PROLONGATION; RHEUMATIC HEART DISEASE; RISK ASSESSMENT; SLEEP APNEA SYNDROME; STABLE ANGINA PECTORIS; STROKE; SYNCOPE; TACHYCARDIA; TORSADE DES POINTES; TRAFFIC ACCIDENT; TREATMENT RESPONSE; WEAKNESS; ARRHYTHMIAS, CARDIAC; BLOOD; COMPLICATION; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; TORSADES DE POINTES; TREATMENT OUTCOME;

ALCOHOLISM; AMIODARONE; ANTIPSYCHOTIC AGENTS; ARRHYTHMIAS, CARDIAC; BIOLOGICAL MARKERS; CITALOPRAM; CYCLOHEXANOLS; DIBENZOTHIAZEPINES; DIURETICS; DOMPERIDONE; DOPAMINE ANTAGONISTS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPOKALEMIA; MAGNESIUM; MIDDLE AGED; POLYPHARMACY; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; TORSADES DE POINTES; TREATMENT OUTCOME;

EID: 77951173602     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Sala M, Vicentini A, Brambilla P et al. QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy. Ann Gen Psychiatry, 2005; 4: 1.
2. Harrigan EP, Miceli JJ, Anziano R et al. A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition. J Clin Psychopharmacol, 2004; 24: 62-69.
3. Papademetriou V. Diuretics, hypokalemia, and cardiac arrhythmia: A 20-year controversy. J Clin Hypertens (Greenwich), 2006; 8: 86-92.
4. Olgin JE, Zipes DP. Specific arrhythmias: Diagnosis and treatment. In: Libby P, Bonow RO, Mann DL, Zipes DP eds. Braunwald's heart disease: A textbook of cardiovascular medicine. 8th Ed. W.B. Saunders Company, Philadelphia 2008: 906.
5. Riera AR, Uchida AH, Ferreira C et al. Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome. Cardiol J, 2008; 15: 209-219.
6. Zeltser D, Justo D, Halkin A, Prokhorov V, Heller K, Viskin S. Torsade de pointes due to noncardiac drugs: Most patients have easily identifiable risk factors. Medicine, 2003; 82: 282-290.
7. Camm AJ, Janse MJ, Roden DM, Rosen MR, Cinca J, Cobbe SM. Congenital and acquired long QT syndrome. Eur Heart J, 2000; 21: 1232-1237.
8. Hohnloser SH, Singh BN. Proarrhythmia with class III antiarrhythmic drugs: Definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications. J Cardiovasc Electrophysiol, 1995; 6 (10 Part 2): 920-936.
9. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med, 2004; 350: 1013-1022.
10. Collins KK, Sondheimer JM. Domperidone-induced QT prolongation: Add another drug to the list. Pediatr, 2008; 153: 596-598.
11. Howell C, Wilson AD, Waring WS. Cardiovascular toxicity due to venlafaxine poisoning in adults: A review of 235 consecutive cases. Br J Clin Pharmacol, 2007; 64: 192-197.
12. Baranchuk A, Simpson CS, Methot M, Gibson K, Strum D. Corrected QT interval prolongation after an overdose of escitalopram, morphine, oxycodone, zopiclone and benzodiazepines. Can J Cardiol, 2008; 24: e38-e40.
13. Kanjanauthai S, Kanluen T, Chareonthaitawee P. Citalopram induced torsade de pointes, a rare life threatening side effect. Int J Cardiol, 2008; 131: e33-e34.
14. Clayton JA, Rodgers S, Blakey J, Avery A, Hall IP. Thiazide diuretic prescription and electrolyte abnormalities in primary care. Br J Clin Pharmacol, 2006; 61: 87-95.
15. Johri A, Baranchuk A, Simpson CS, Abdollah H, Redfearn DP. ECG manifestations of multiple electrolyte imbalance: Peaked T-wave to P-wave (Tee-pee Sign). Ann Noninvasive Electrocardiol, 2009; 14: 211-214.
16. Elisaf M, Liberopoulos E, Bairaktari E, Siamopoulos K. Hypokalaemia in alcoholic patients. Drug Alcohol Rev, 2002; 21: 73-76.
17. Bar KJ, Boettger MK, Koschke M et al. Increased QT interval variability index in acute alcohol withdrawal. Drug Alcohol Depend, 2007; 89: 259-266.